Version 2 2020-10-19, 18:23Version 2 2020-10-19, 18:23
Version 1 2020-09-29, 19:26Version 1 2020-09-29, 19:26
figure
posted on 2020-10-19, 18:23authored byAda AdminAda Admin, Hao Wang, Kouichi Mizuno, Noriko Takahashi, Eri Kobayashi, Jun Shirakawa, Yasuo Terauchi, Haruo Kasai, Katsuhide Okunishi, Tetsuro Izumi
Direct observation of fluorescence-labeled
secretory granule exocytosis in living pancreatic β cells has revealed
heterogeneous prefusion behaviors: some granules dwell beneath the plasma
membrane before fusion, while others fuse immediately once they are recruited
to the plasma membrane. Although the former mode seems to follow sequential
docking-priming-fusion steps as found in synaptic vesicle exocytosis, the
latter mode, which is unique to secretory granule exocytosis, has not been
explored well. Here, we show that melanophilin, one of the effectors of the
monomeric GTPase Rab27 on the granule membrane, is involved in such an
accelerated mode of exocytosis. Both melanophilin-mutated leaden mouse and melanophilin-downregulated human pancreatic β
cells exhibit impaired glucose-stimulated insulin secretion, with a specific
reduction in fusion events that bypass stable docking to the plasma membrane. Upon
stimulus-induced [Ca2+]i
rise, melanophilin mediates this type of fusion by dissociating granules from
myosin-Va and actin in the actin cortex and by associating them with a fusion-competent,
open form of syntaxin-4 on the plasma membrane. These findings provide the
hitherto unknown mechanism to support sustainable exocytosis by which granules
are recruited from the cell interior and fuse promptly without stable
predocking to the plasma membrane.
Funding
This work was supported by JSPS KAKENHI grants JP26670133, JP14F04104, and JP16K15211 to T.I., JP18K14647 and JP20K15742 to H.W., and JST-CREST grant JPMJCR1652 to H.K. It was also supported by grants from Uehara Memorial Foundation, Kobayashi International Scholarship Foundation, Novartis Research Grants, Pfizer Academic Contributions, Astellas Research Support, MSD Scholarship Donation, and Sanofi Scholarship Donation to T.I.